• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Pioneer Floating Rate

Pioneer Floating Rate

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Newly Published Data Confirm the Safety and Efficacy of the Carillon® Mitral Contour System®

    Newly Published Data Confirm the Safety and Efficacy of the Carillon® Mitral Contour System®

  2. UPDATE: One of the biggest life regrets for older Americans is ...

    UPDATE: One of the biggest life regrets for older Americans is ...

  3. The University of Texas System Expands Partnership with Premier Inc.

    The University of Texas System Expands Partnership with Premier Inc.

  4. Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation

    Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation

  5. Idiopathic Pulmonary Fibrosis EpiCast Report 2016 - Epidemiology Forecast to 2025 - Research and Markets

    Idiopathic Pulmonary Fibrosis EpiCast Report 2016 - Epidemiology Forecast to 2025 - Research and Markets

  6. Kiadis Pharma and The Leukemia & Lymphoma Society strengthen partnership around the development of ATIR101™ in ALL and AML patients

    Kiadis Pharma and The Leukemia & Lymphoma Society strengthen partnership around the development of ATIR101™ in ALL and AML patients

  7. UPDATE: One of the biggest life regrets for older Americans is ...

    UPDATE: One of the biggest life regrets for older Americans is ...

  8. The U.S. is ripe for bubbles in stocks and real estate

    The U.S. is ripe for bubbles in stocks and real estate

  9. ADRs End Down; Oil and Gold Companies Trade Actively

    ADRs End Down; Oil and Gold Companies Trade Actively

  10. Poxel Announces Patient Enrollment Completed for Imeglimin Phase 2b Clinical Trial in Type 2 Diabetes in Japan

    Poxel Announces Patient Enrollment Completed for Imeglimin Phase 2b Clinical Trial in Type 2 Diabetes in Japan

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.